Culture Watch Update
SEE OTHER BRANDS

Your top news on culture, society and lifestyle

Culture Watch Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Culture Watch Update.

Press releases published on April 1, 2025

"Me Enamoré" lleva a La Original Banda El Limón de Salvador Lizárraga al #1 en Varios Charts

"Me Enamoré" lleva a La Original Banda El Limón de Salvador Lizárraga al #1 en Varios Charts

"Me Enamoré" También Arrasa en Monitor Latino: #1 en Regional Mexicano y General LOS ANGELES, CA, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- ICCF-- La Original Banda El Limón de Salvador Lizárraga sigue imparable con su más reciente éxito, "Me …

REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

BRAINTREE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, is providing this reminder that data from the Company’s ACCESS-PVI trial will be presented by …

Clene to Present at the Jones Healthcare and Technology Innovation Conference

Clene to Present at the Jones Healthcare and Technology Innovation Conference

SALT LAKE CITY, April 01, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the …

Cannabix Technologies to Attend U.S. National Drug and Alcohol Conference to Market Marijuana Breath Test

Cannabix Technologies to Attend U.S. National Drug and Alcohol Conference to Market Marijuana Breath Test

VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that it will …

10 Winners Awarded “Justies” at Cellebrite’s First-Ever Digital Justice Awards

10 Winners Awarded “Justies” at Cellebrite’s First-Ever Digital Justice Awards

TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a global leader in Digital Investigative (DI) solutions for the public and private sectors, awarded ten winners “Justies” at the Company’s inaugural …

Minnesota Twins, Fox 9 and Gray Media Announce 10-game, Free Over-the-air Television Package

Minnesota Twins, Fox 9 and Gray Media Announce 10-game, Free Over-the-air Television Package

Twins return to over-the-air TV for first time since 2012 with 10 Tuesday games on FOX 9; 10 Gray Media stations ensure first outer market Twins Territory OTA coverage since 1988 ATLANTA, April 01, 2025 (GLOBE NEWSWIRE) -- Bringing Minnesota Twins baseball …

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

PARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark publication in the Mayo Clinic Proceedings. The …

Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress

Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress

CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of …

Nkarta to Participate in an April Investor Conference

Nkarta to Participate in an April Investor Conference

SOUTH SAN FRANCISCO, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference: 24th …

Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference

Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference

HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- MARKER THERAPEUTICS, INC. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid …

electroCore to Participate at the Needham Virtual Healthcare Conference

electroCore to Participate at the Needham Virtual Healthcare Conference

ROCKAWAY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Conference taking place …

A Journey to the Heart of Kumari Debut YA Fantasy Braids Ancient Nepalese Mystery with Spiritual Awakening

A Journey to the Heart of Kumari Debut YA Fantasy Braids Ancient Nepalese Mystery with Spiritual Awakening

Debut YA Fantasy Braids Ancient Nepalese Mystery with Spiritual Awakening. LEHIGH ACRES, FL, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- Guardians of a Secret Legacy Marks a Powerful Debut in A Journey to the Heart of Kumari Trilogy Author K. …

Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025

Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025

MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2025 after the close of trading on Monday, May 5. Inspire’s management team will host a corresponding …

FeraMAXᴹᴰ est la marque de supplément de fer que les pharmaciens et les médecins au Canada recommandent le plus souvent depuis dix années consécutives

FeraMAXᴹᴰ est la marque de supplément de fer que les pharmaciens et les médecins au Canada recommandent le plus souvent depuis dix années consécutives

MISSISSAUGA, Ontario, 01 avr. 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent », titre à la Bourse de croissance TSX : RX) est fière d’annoncer que FeraMAXMD est la marque de supplément de fer la plus recommandée au Canada selon un sondage pancanadien …

FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Tenth Consecutive Year

FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Tenth Consecutive Year

MISSISSAUGA, Ontario, April 01, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX® is the #1 recommended iron supplement brand in Canada, based on a national survey of Canadian pharmacists and …

Merus nimmt an Kamingespräch auf der 24. jährlichen Needham Virtual Healthcare Conference teil

Merus nimmt an Kamingespräch auf der 24. jährlichen Needham Virtual Healthcare Conference teil

UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, April 01, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein Unternehmen für klinische Onkologie, das innovative, multispezifische Antikörper in voller Länge und Antikörper-Wirkstoff-Konjugate ( …

Merus participera à une discussion informelle lors de la 24e conférence annuelle Needham Virtual Healthcare

Merus participera à une discussion informelle lors de la 24e conférence annuelle Needham Virtual Healthcare

UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachussets, 01 avr. 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), entreprise spécialisée en oncologie développant des anticorps de pleine longueur multispécifiques et des conjugués anticorps-médicament …

Pacira BioSciences to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

Pacira BioSciences to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

BRISBANE, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will …

Avalyn Completes Successful Phase 1 Clinical Trials of AP02, its Novel Inhaled Formulation of Nintedanib, Preparing for Phase 2 Development in Idiopathic Pulmonary Fibrosis

Avalyn Completes Successful Phase 1 Clinical Trials of AP02, its Novel Inhaled Formulation of Nintedanib, Preparing for Phase 2 Development in Idiopathic Pulmonary Fibrosis

Topline data from the single- and multiple-ascending dose studies confirmed safety and favorable tolerability profile of AP02 at all dose levels Full safety, tolerability, and pharmacokinetics data to be presented at the American Thoracic Society 2025 …

NASM's New Golf Fitness Specialization Set to Transform the Industry

NASM's New Golf Fitness Specialization Set to Transform the Industry

Gilbert, Arizona, April 01, 2025 (GLOBE NEWSWIRE) -- National Academy of Sports Medicine (NASM), the global leader in fitness and wellness training and certifications, is thrilled to announce the launch of its reimagined Golf Fitness Specialization (GFS) …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service